[
  {
    "ts": null,
    "headline": "Becton Dickinson (BDX): Evaluating Valuation After Recent Stretch of Quiet Trading",
    "summary": "Becton Dickinson (BDX) shares have moved in a fairly narrow range this past week, with little in the way of major news or company updates to spark momentum. Investors may be reevaluating the stock's recent returns and valuation. See our latest analysis for Becton Dickinson. This recent stretch of subdued trading follows a year where Becton Dickinson’s share price has slid, with a year-to-date price return of -17.64% and a total shareholder return over the past year of -20.19%. The longer-term...",
    "url": "https://finnhub.io/api/news?id=0d74193fc79d2f85b818a4f71ca43142bcc916264290c14eca6d3dce871cb6ff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761332995,
      "headline": "Becton Dickinson (BDX): Evaluating Valuation After Recent Stretch of Quiet Trading",
      "id": 137217315,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Becton Dickinson (BDX) shares have moved in a fairly narrow range this past week, with little in the way of major news or company updates to spark momentum. Investors may be reevaluating the stock's recent returns and valuation. See our latest analysis for Becton Dickinson. This recent stretch of subdued trading follows a year where Becton Dickinson’s share price has slid, with a year-to-date price return of -17.64% and a total shareholder return over the past year of -20.19%. The longer-term...",
      "url": "https://finnhub.io/api/news?id=0d74193fc79d2f85b818a4f71ca43142bcc916264290c14eca6d3dce871cb6ff"
    }
  },
  {
    "ts": null,
    "headline": "Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings",
    "summary": "CAH's Pharmaceutical and Specialty units are expected to have fueled double-digit revenue growth in Q1 FY26 despite tariff and cost headwinds.",
    "url": "https://finnhub.io/api/news?id=cba26f9d8760318a6639c6e9187cd65d23da4b017d067e46ec9b6df24f59ba12",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761310680,
      "headline": "Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings",
      "id": 137216577,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "CAH's Pharmaceutical and Specialty units are expected to have fueled double-digit revenue growth in Q1 FY26 despite tariff and cost headwinds.",
      "url": "https://finnhub.io/api/news?id=cba26f9d8760318a6639c6e9187cd65d23da4b017d067e46ec9b6df24f59ba12"
    }
  },
  {
    "ts": null,
    "headline": "1 Cash-Producing Stock with Exciting Potential and 2 We Turn Down",
    "summary": "A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.",
    "url": "https://finnhub.io/api/news?id=b8162552f0e1e6513d663048b2a7665f86b57f884c5ad20f57fcca88cbd67e27",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761280923,
      "headline": "1 Cash-Producing Stock with Exciting Potential and 2 We Turn Down",
      "id": 137217317,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.",
      "url": "https://finnhub.io/api/news?id=b8162552f0e1e6513d663048b2a7665f86b57f884c5ad20f57fcca88cbd67e27"
    }
  }
]